1'-(4-methylphenylsulfonyl)spiro[1H-indene-1,4'-(hexahydropyridine)]

ID: ALA341490

Chembl Id: CHEMBL341490

PubChem CID: 9797987

Max Phase: Preclinical

Molecular Formula: C20H21NO2S

Molecular Weight: 339.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1

Standard InChI:  InChI=1S/C20H21NO2S/c1-16-6-8-18(9-7-16)24(22,23)21-14-12-20(13-15-21)11-10-17-4-2-3-5-19(17)20/h2-11H,12-15H2,1H3

Standard InChI Key:  VRVIZJNFYYAUKC-UHFFFAOYSA-N

Associated Targets(Human)

OXTR Tclin Oxytocin receptor (1962 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Oxtr Oxytocin receptor (839 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Avpr1b Vasopressin receptor (377 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Avpr1a Vasopressin V1a receptor (612 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Avpr2 Vasopressin V2 receptor (776 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 339.46Molecular Weight (Monoisotopic): 339.1293AlogP: 3.74#Rotatable Bonds: 2
Polar Surface Area: 37.38Molecular Species: HBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.88CX LogD: 3.88
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.84Np Likeness Score: -0.76

References

1. Evans BE, Leighton JL, Rittle KE, Gilbert KF, Lundell GF, Gould NP, Hobbs DW, DiPardo RM, Veber DF, Pettibone DJ..  (1992)  Orally active, nonpeptide oxytocin antagonists.,  35  (21): [PMID:1331449] [10.1021/jm00099a020]
2. Borthwick AD..  (2010)  Oral oxytocin antagonists.,  53  (18): [PMID:20550119] [10.1021/jm901812z]

Source